LGALS3 and heart failure: With HFpEF specifically, a prospective study by de Boer et al. showed that the prognostic ability of Gal-3 for the primary outcome all-cause mortality and heart failure hospitalizations was stronger in HFpEF patients compared to HFrEF patients although the overall levels of Gal-3 were similar in both groups (67).